Neuromodulation Devices and Implantable Infusion Pumps Market Report – Research, Industry Analysis Reports and Market Demands

Global Neuromodulation Devices and Implantable Infusion Pumps Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Neuromodulation Devices
- 1.3.3 Implantable Infusion Pumps
1.4 Market Analysis by Neuromodulation Device Type
- 1.4.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Neuromodulation Device Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Spinal Cord Stimulation Systems
- 1.4.3 Brain Stimulation Systems
- 1.4.4 Sacral Neuromodulation Systems
- 1.4.5 Cranial Nerve Stimulation Systems
- 1.4.6 Peripheral Nerve Stimulation Systems
1.5 Market Analysis by Implantable Pump Type
- 1.5.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Implantable Pump Type: 2021 Versus 2025 Versus 2032
- 1.5.2 Programmable Variable-Rate Pumps
- 1.5.3 Constant-Flow Pumps
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Chronic Pain
- 1.6.3 Parkinson's Disease
- 1.6.4 Sleep-Disordered Breathing
- 1.6.5 Urologic Disorders
- 1.6.6 Epilepsy
- 1.6.7 Spasticity
- 1.6.8 Other Therapeutic Applications
1.7 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size & Forecast
- 1.7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2021-2032)
- 1.7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer

3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
- 3.4.3 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
3.5 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
- 3.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
- 3.5.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
- 3.5.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
- 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
- 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
- 4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2032)
4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2021-2032)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2021-2032)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032)

7 North America

7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
- 7.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
- 7.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
8.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
- 8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
- 9.3.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
10.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
- 10.3.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
- 10.3.2 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
- 11.3.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
12.3 Neuromodulation Devices and Implantable Infusion Pumps Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Neuromodulation Devices and Implantable Infusion Pumps and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neuromodulation Devices and Implantable Infusion Pumps
13.3 Neuromodulation Devices and Implantable Infusion Pumps Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
14.3 Neuromodulation Devices and Implantable Infusion Pumps Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at US$ 7675 million in 2025 and is forecast to a readjusted size of US$ 12145 million by 2032 with a CAGR of 6.7% during review period.
Neuromodulation devices and implantable infusion pumps are surgically implanted therapeutic systems that modify neural activity through electrical stimulation or deliver controlled medication directly into the intrathecal space, making them important treatment platforms for chronic pain, movement disorders, epilepsy, sleep-disordered breathing, urinary dysfunction, severe spasticity, and selected refractory neurological conditions.
Upstream supply is concentrated in medical-grade batteries, application-specific integrated circuits, hermetic titanium housings, ceramic or glass feedthroughs, platinum-iridium electrodes, silicone and polyurethane insulation, precision pump mechanisms, catheters, telemetry modules, sterilization services, and validated medical software. Suppliers must maintain long-term material traceability, biocompatibility, hermeticity, electrical safety, cybersecurity, and process-validation capabilities. Downstream buyers are mainly specialist hospitals, neurosurgery centers, pain clinics, epilepsy centers, sleep laboratories, urology departments, rehabilitation centers, and public healthcare systems. Procurement commonly uses annual hospital frameworks, group purchasing agreements, public tenders, distributor contracts, consignment inventories, and case-specific purchasing tied to scheduled implantation procedures.
In the current market, global production is around 252,000 Units, with an average selling price of about 29,600 USD per Unit. The market is highly concentrated because regulatory approvals, multicenter clinical evidence, physician training networks, reimbursement coverage, implant reliability, and long-term patient-support infrastructure are difficult to replicate. The Top 5 suppliers control approximately 76% of global revenue CR5. Medtronic, Boston Scientific, and Abbott operate broad platforms across spinal cord stimulation, deep brain stimulation, sacral neuromodulation, and implantable drug delivery, while Inspire Medical Systems and LivaNova hold strong positions in hypoglossal and vagus nerve stimulation. North America is the principal demand center because of established reimbursement pathways, a large specialist-center network, and comparatively rapid adoption of premium implantable systems. Europe is the second major market, supported by established DBS, SCS, VNS, and infusion-pump use, although national reimbursement conditions vary. China remains smaller in revenue terms but is becoming more important in unit demand as domestic manufacturers expand DBS, SCS, VNS, SNM, and implantable drug-delivery portfolios. The hardware-weighted industry gross margin is estimated at 72.0% in 2025.
During 2026–2032, market development will be shaped by closed-loop stimulation, sensing-enabled implants, adaptive programming, smaller rechargeable devices, extended battery life, remote monitoring, expanded MRI compatibility, and broader indications. AI-assisted programming is expected to improve signal classification, therapy selection, parameter optimization, and clinician workflow, but algorithms incorporated into therapeutic decisions will face stricter validation, cybersecurity, change-control, and post-market surveillance requirements. Replacement demand will remain structurally important because implanted batteries, leads, catheters, and pump mechanisms have finite service lives, although longer-life batteries and rechargeable architectures will lengthen some replacement intervals.
This report is a detailed and comprehensive analysis for global Neuromodulation Devices and Implantable Infusion Pumps market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation Devices and Implantable Infusion Pumps
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, Inspire Medical Systems, LivaNova, Globus Medical, NeuroPace, BIOTRONIK, Saluda Medical, Mainstay Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Neuromodulation Devices
Implantable Infusion Pumps
Market segment by Neuromodulation Device Type
Spinal Cord Stimulation Systems
Brain Stimulation Systems
Sacral Neuromodulation Systems
Cranial Nerve Stimulation Systems
Peripheral Nerve Stimulation Systems
Market segment by Implantable Pump Type
Programmable Variable-Rate Pumps
Constant-Flow Pumps
Market segment by Application
Chronic Pain
Parkinson's Disease
Sleep-Disordered Breathing
Urologic Disorders
Epilepsy
Spasticity
Other Therapeutic Applications
Major players covered
Medtronic
Boston Scientific
Abbott
Inspire Medical Systems
LivaNova
Globus Medical
NeuroPace
BIOTRONIK
Saluda Medical
Mainstay Medical
Nalu Medical
Infusyn Therapeutics
ZOLL Medical
Beijing PINS Medical
SceneRay
Rishena
Nurotron
Hangzhou Chengnuo Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales quantity, revenue, and global market share of Neuromodulation Devices and Implantable Infusion Pumps from 2021 to 2026.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices and Implantable Infusion Pumps.
Chapter 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion.

Buy now